Diabetes: A Lifestyle Disease Treated as a Drug Deficiency Most experts agree on a basic truth: diet and lifestyle are the primary drivers of type 2 diabetes—and therefore the keys to preventing and reversing it. Yet despite this consensus, diabetes has become one of the most aggressively medicated conditions of our time. With over 10% of the U.S. population diagnosed with diabetes and an additional one-third considered pre-diabetic, the market is simply too large for pharmaceutical companies to ignore. Instead of addressing root causes, the public is repeatedly told that blood sugar dysregulation is a problem best managed with pills. It isn’t. And in many cases, those pills create new—and sometimes more dangerous—problems. A Case in Point: Invokana Introduced in 2013, Invokana (generic name: canagliflozin) was the first drug in a new class of diabetes medications known as SGLT2 inhibitors (sodium-glucose co-transporter-2 inhibitors) approved by the U.S. Food a…